PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsCommon cold
MeSH D003139 - common cold
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010850:Picornaviridae infections
0 Companies
0 Drugs
Success rate
D012141:Respiratory tract infections
D003139: 
Common cold
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsAscorbic acid, Polyethylene glycol 3350 Moviprep 2024-09-01 2006-08-02   
Ascorbic acid, Polyethylene glycol 3350 Plenvu 2032-03-09 2018-05-04   
TevaBrompheniramine Brompheniramine  1982-01-01   
Pseudoephedrine, Cetirizine Cetirizine Pseudoephedrine  2008-02-25   
Pseudoephedrine, Triprolidine Triphed  1984-05-17   
Pseudoephedrine, Triprolidine Triprolidine Pseudoephedrine  1984-12-12   
PadagisDextromethorphan, Pseudoephedrine, Brompheniramine Brompheniramine Maleate, Pseudoephedrine Dextromethorphan  2014-07-15   
Pseudoephedrine, Hydrocodone, Chlorpheniramine Hydrocodone Bitartrate, Chlorpheniramine Pseudoephedrine  2014-04-29   
Pseudoephedrine, Hydrocodone Hydrocodone Pseudoephedrine  2014-04-29   
Taro PharmaceuticalDextromethorphan, Pseudoephedrine, Brompheniramine Brompheniramine Maleate, Pseudoephedrine Dextromethorphan  2017-02-27   
Oxymetazoline Oxymetazoline  2021-10-04   
MylanEsomeprazole, Naproxen Naproxen Esomeprazole Magnesium  2021-07-20   
Mayne GroupPseudoephedrine, Hydrocodone, Chlorpheniramine Hydrocodone Bitartrate, Chlorpheniramine Pseudoephedrine  2015-08-03   
Pseudoephedrine, Hydrocodone Hydrocodone Pseudoephedrine  2015-11-17   
Oxymetazoline Rhofade 2024-01-22 2017-01-18   
Johnson & JohnsonIbuprofen, Pseudoephedrine Motrin  2000-08-01   
Ibuprofen, Pseudoephedrine Sine-aid  1992-12-31   
Pseudoephedrine Sudafed  1992-12-15   
Oxymetazoline Visine  1989-03-31   
Pseudoephedrine, Cetirizine Zyrtec 2022-06-10 2007-11-09   
PerrigoPseudoephedrine, Cetirizine Cetirizine Pseudoephedrine  2018-11-16   
Guaifenesin Guaifenesin  2011-11-23   
Dextromethorphan, Guaifenesin Guaifenesin Dextromethorphan  2018-03-05   
Pseudoephedrine, Guaifenesin Guaifenesin Pseudoephedrine  2022-02-01   
Ibuprofen, Pseudoephedrine Ibuprofen Pseudoephedrine  2003-11-05   
Pseudoephedrine, Loratadine Loratadine Pseudoephedrine  2004-03-04   
Naproxen, Diphenhydramine Naproxen Diphenhydramine  2019-05-10   
Pseudoephedrine, Naproxen Naproxen Pseudoephedrine  2004-03-17   
Pseudoephedrine Pseudoephedrine  1999-02-26   
P&L Developments (PLD)Pseudoephedrine, Loratadine Loratadine Pseudoephedrine  2003-02-21   
Naproxen, Diphenhydramine Naproxen Diphenhydramine  2019-01-25   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
78%
7/9
Phase 2
46%
6/13
Phase 3
69%
18/26
Approved: 8Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Taro Pharmaceutical
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use